Quarterly report [Sections 13 or 15(d)]

Note 14 - Segment Information

v3.26.3
Note 14 - Segment Information
9 Months Ended
Sep. 30, 2026
Notes to Financial Statements  
Segment Reporting [Text Block]

14.         Segment Information

 

An operating segment is identified as a component of an enterprise that engages in business activities about which separate discrete financial information and operating results is regularly reviewed by the chief operating decision-maker (CODM) in making decisions regarding resource allocation and assessing performance. The Company's CODM is the Chief Executive Officer. The Company operates in a single operating segment focused on the development of its drug product candidate DM199 for the treatment of severe ischemic disease. The CODM manages and allocates resources to the operations of the Company on a total company basis. Further, the CODM reviews and utilizes functional expenses (i.e., research, development and general and administrative) at the consolidated level to manage the Company's operations. Other segment items included in consolidated net loss are share-based compensation, interest income, other income (expense), net, and income tax expense, which are reflected in the condensed consolidated statements of operations and comprehensive loss. The measure of segment assets is reported on the condensed consolidated balance sheet as total consolidated assets.

 

The following table presents financial information, including significant segment expenses, which are regularly provided to the CODM and included within segment and consolidated net loss:

 

   

Three Months Ended

September 30,

   

Nine Months Ended

September 30,

 
   

2026

   

2025

   

2026

   

2025

 

Operating expenses, excluding share-based compensation

                               

Research and development

  $ 8,524     $ 6,067     $ 23,849     $ 17,123  

General and administrative

    1,564       1,950       5,279       5,407  

Total operating expenses, excluding share-based compensation

    10,088       8,017       29,128       22,530  

Share-based compensation

                               

Research and development

    719       370       1,534       792  

General and administrative

    814       646       1,939       1,862  

Total share-based compensation

    1,533       1,016       3,473       2,654  

Operating loss

    (11,621 )     (9,033 )     (32,601 )     (25,184 )

Interest income

    314       440       1,169       1,197  

Other income (expense), net

    5       (21 )     (37 )     (21 )

Income tax expense

    (8 )     (6 )     (22 )     (18 )

Segment and consolidated net loss

  $ (11,310 )   $ (8,620 )   $ (31,491 )   $ (24,026 )